Accueil539523 • BOM
add
Alkem Laboratories Ltd
Dernière clôture
4 723,95 ₹
Variation sur la journée
4 609,50 ₹ - 4 752,90 ₹
Plage sur l'année
4 409,90 ₹ - 6 440,00 ₹
Capitalisation boursière
553,45 Md INR
Volume moyen
3,59 k
Ratio cours/bénéfices
25,73
Rendement (dividendes)
0,91 %
Place boursière principale
NSE
Actualités
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(INR) | déc. 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 33,74 Md | 1,52 % |
Charges d'exploitation | 14,96 Md | 8,29 % |
Résultat net | 6,26 Md | 5,19 % |
Marge bénéficiaire nette | 18,55 | 3,63 % |
Bénéfice par action | 52,34 | -2,59 % |
EBITDA | 7,39 Md | 4,74 % |
Taux d'imposition effectif | 12,35 % | — |
Bilan
Total des actifs
Total du passif
(INR) | déc. 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 22,89 Md | -36,59 % |
Total des actifs | — | — |
Total du passif | — | — |
Total des capitaux propres | 119,10 Md | — |
Actions en circulation | 119,57 M | — |
Ratio cours/valeur comptable | 4,91 | — |
Rentabilité des actifs | — | — |
Retour sur capitaux | 12,59 % | — |
Flux de trésorerie
Variation nette en trésorerie
(INR) | déc. 2024info | Variation Y/Y |
---|---|---|
Résultat net | 6,26 Md | 5,19 % |
Trésorerie (opérations) | — | — |
Trésorerie (invest.) | — | — |
Trésorerie (financement) | — | — |
Variation nette en trésorerie | — | — |
Flux de trésorerie dispo. | — | — |
À propos
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Date de fondation
1973
Siège social
Site Web
Employés
17 432